Prospective observational study reveals that cytokine gene polymorphisms impact pain and radiotherapy response in multiple myeloma, implying potential treatment adjustments.
Findings of this study emphasize the importance of gene polymorphisms which encode inflammatory interleukins in the severity of pain and response to palliative radiotherapy. Regional research ethical committee number BE-2-39 ClinicalTrials.gov registration number NCT02024815.
No takes yet. Share an insight, caveat, or question.
Rudžianskienė et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: